Tolterodine Tartrate Capsule, Extended Release
Product Images NDC 27241-191

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 27241-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2mg (Tolterodine 2mg)

Each extended-release capsule contains 2mg of tolterodine tartrate, USP. This medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with permitted excursions to 15°C to 30°C (59°F to 86°F). It should be protected from light and kept out of children's reach. This package is child-resistant. Ajanta Pharma USA Inc. marketed the product, and it was made in India. The code No. is GUJDRUGS/G/25/2080, and the product contains 30 capsules. Please refer to the package insert for complete prescribing information.*

FDA Label Image

4mg (Tolterodine 4mg)

This is a medication that comes in extended-release capsules and contains tolterodine tartrate USP 4 mg. The package insert should be consulted for the usual dosage and full prescribing information. The medication should be stored between 20°C to 25°C (68°F to 77°F) and protected from light. The capsules are child-resistant and caution should be taken to keep them out of reach of children. The medication is marketed by Ajanta Pharma USA Inc. and is made in India.*

FDA Label Image

Structure (Tolterodine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.